Cost-effectiveness analysis of hip fracture prevention with vitamin D supplementation: A Markov micro-simulation model applied to the French population over 65 years old without previous hip fracture

Osteoporosis International

Volumn 25, Issue 6, 2014, Pages 1797-1806

  Zarca, K ^a,b   Durand Zaleski, I ^b,c,d,o   Roux, C ^e,f,g   Souberbielle, J C ^f,h   Schott, A M ^i,j   Thomas, T ^k   Fardellone, P ^l,m   Benhamou, C L ⁿ  

^a HÔTEL DIEU   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c URC Eco Ile de France   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e Institut Cochin   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g PARIS DESCARTES UNIVERSITY   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ HOSPICES CIVILS DE LYON   (France)

^j University of Lyon Claude Bernard   (France)

^k UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^l AMIENS UNIVERSITY HOSPITAL   (France)

^m UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

ⁿ Hospital of Orleans   (France)

^o INSERM   (France)

more..

Author keywords

Elderly; Health economics; Hip fracture; Model; Supplementation; Vitamin D

Indexed keywords

VITAMIN D; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HIDDEN MARKOV MODEL; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; POPULATION; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING; SENSITIVITY ANALYSIS; SOCIETY; VERY ELDERLY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; COST BENEFIT ANALYSIS; DIET SUPPLEMENTATION; DRUG COST; ECONOMICS; EPIDEMIOLOGY; FRANCE; HEALTH CARE COST; HEALTH SERVICES RESEARCH; HIP FRACTURES; MEDICATION COMPLIANCE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PROBABILITY; PROCEDURES; RECURRENT DISEASE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; COST-BENEFIT ANALYSIS; DIETARY SUPPLEMENTS; DRUG COSTS; FEMALE; FRANCE; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HIP FRACTURES; HUMANS; INCIDENCE; MALE; MARKOV CHAINS; MASS SCREENING; MEDICATION ADHERENCE; MODELS, ECONOMETRIC; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84901847612     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2698-1     Document Type: Article

References (47)

1. Mithal A, Wahl DA, Bonjour JP et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20:1807-1820. doi: 10.1007/s00198-009-0954-6
2. Borgström F, Lekander I, Ivergård M et al (2013) The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS) - quality of life during the first 4 months after fracture. Osteoporos Int 24:811-823. doi: 10.1007/s00198-012-2240-2
3. Bleibler F, Konnopka A, Benzinger P et al (2013) The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany - a demographic simulation model. Osteoporos Int 24:835-847. doi: 10.1007/s00198-012-2020-z
4. McGowan B, Casey MC, Silke C et al (2013) Hospitalisations for fracture and associated costs between 2000 and 2009 in Ireland: a trend analysis. Osteoporos Int 24:849-857. doi: 10.1007/s00198-012-2032-8
5. (2011) La vitamine D chez l'adulte: recommandations du GRIO. La Presse Médicale 40:673-682. doi: 10.1016/j.lpm.2011.04.001
6. Bischoff-Ferrari HA, Willett WC, Orav EJ et al (2012) A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 367:40-49. doi: 10.1056/NEJMoa1109617
7. Sattar N, Welsh P, Panarelli M, Forouhi NG (2012) Increasing requests for vitamin D measurement: costly, confusing, and without credibility. Lancet 379:95-96. doi: 10.1016/S0140-6736(11)61816-3
8. Sonnenberg FA, Beck JR (1993) Markov models in medical decision making. Med Decis Mak 13:322-338. doi: 10.1177/0272989X9301300409
9. Siebert U, Alagoz O, Bayoumi AM et al (2012) State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force - 3. Value Health 15:812-820. doi: 10.1016/j.jval.2012.06.014
10. Development Core Team R (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
11. Kanis JA, Johnell O, Oden A et al (2004) The risk and burden of vertebral fractures in Sweden. Osteoporos Int 15:20-26. doi: 10.1007/s00198-003-1463-7
12. Jönsson B, Christiansen C, Johnell O et al (1996) Cost-effectiveness of fracture prevention in established osteoporosis. Scand J Rheumatol Suppl 103:30-38, discussion 39-40
13. Burström K, Johannesson M, Diderichsen F (2001) Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 10:621-635
14. [INED] Table de mortalité. http://www.ined.fr/fr/pop-chiffres/ france/mortalite-causes-deces/table-mortalite/. Accessed 4 April 2013
15. Haentjens P, Magaziner J, Colón-Emeric CS et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380-390. doi: 10.1059/0003-4819-152-6-201003160-00008
16. Maravic M, Taupin P, Landais P, Roux C (2011) Change in hip fracture incidence over the last 6 years in France. Osteoporos Int 22:797-801. doi: 10.1007/s00198-010-1255-9
17. Ryg J, Rejnmark L, Overgaard S et al (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res 24:1299-1307. doi: 10.1359/jbmr.090207
18. Bischoff-Ferrari HA, Willett WC, Wong JB et al (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169:551-561. doi: 10.1001/archinternmed.2008.600
19. UVEDOSE 100 000 UI SOL BUV. http://www.vidal.fr/Medicament/uvedose-17128. htm. Accessed 26 April 2013
20. ameli.fr - l'Assurance Maladie en ligne. http://www.ameli.fr/. Accessed 26 April 2013
21. Sabaté E (2003) Adherence to long-term therapies: evidence for action. World Health Organization
22. Doubilet P, Begg CB, Weinstein MC et al (1985) Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 5:157-177
23. Pasta DJ, Taylor JL, Henning JM (1999) Probabilistic sensitivity analysis incorporating the bootstrap an example comparing treatments for the eradication of Helicobacter pylori. Med Decis Making 19:353-363. doi: 10.1177/ 0272989X9901900314
24. JAMAevidence | Glossary: C. http://jamaevidence.com/glossary/C. Accessed 24 June 2013
25. Fenwick E (2005) A guide to cost-effectiveness acceptability curves. Br J Psychiatry 187:106-108. doi: 10.1192/bjp.187.2.106
26. Eddy DM, Hollingworth W, Caro JJ et al (2012) Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Value Health 15:843-850. doi: 10.1016/j.jval.2012.04.012
27. WHO | Table: Threshold values for intervention cost-effectiveness by Region. In: WHO. http://www.who.int/choice/costs/CER-levels/en/index.html. Accessed 8 April 2013
28. Kanis JA, Johnell O, Oden A et al (2000) Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporos Int 11:120-127. doi: 10.1007/PL00004173
29. Willis MS (2002) The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden. Int J Technol Assess Health Care 18:791-807. doi: 10.1017/S0266462302000600
30. Fleurence RL (2004) Cost-effectiveness of fracture prevention treatments in the elderly. Int J Technol Assess Health Care 20:184-191
31. Lee RH, Weber T, Colón-Emeric C (2013) Comparison of cost-effectiveness of vitamin D screening with that of universal supplementation in preventing falls in community-dwelling older adults. J Am Geriatr Soc. doi: 10.1111/jgs.12213
32. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266-281. doi: 10.1056/NEJMra070553
33. Souberbielle JC, Body J-J, Lappe JM et al (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9:709-715. doi: 10.1016/j.autrev.2010.06.009
34. Autier P, Gandini S (2007) Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167:1730-1737. doi: 10.1001/archinte.167.16.1730
35. Looker AC (2013) Serum 25-hydroxyvitamin D and risk of major osteoporotic fractures in older U.S. adults. J Bone Miner Res 28:997-1006. doi: 10.1002/jbmr.1828
36. Kruk ME, Schwalbe N (2006) The relation between intermittent dosing and adherence: preliminary insights. Clin Ther 28:1989-1995. doi: 10.1016/j.clinthera.2006.12.011
37. Rouillon V, Dubourg G, Gauvain JB et al (2012) Vitamin D insufficiency: evaluation of an oral standardized supplementation using 100,000 IU vials of cholecalciferol, depending on initial serum level of 25OH vitamin D. Joint Bone Spine 79:399-402. doi: 10.1016/j.jbspin.2011.09.004
38. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B et al (2010) Benefit-risk assessment of vitamin D supplementation. Osteoporos Int 21:1121-1132. doi: 10.1007/s00198-009-1119-3
39. Sanders KM, Stuart AL, Williamson EJ et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815-1822. doi: 10.1001/jama.2010.594
40. Farrell C, Soldo J, Williams P, Herrmann M (2012) 25-Hydroxyvitamin D testing: challenging the performance of current automated immunoassays. Clin Chem Lab Med 50:1953-1963. doi: 10.1515/cclm-2012-0522
41. Barake M, Daher RT, Salti I et al (2012) 25-Hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab 97:835-843. doi: 10.1210/jc.2011-2584
42. Stepman HCM, Vanderroost A, Van Uytfanghe K, Thienpont LM (2011) Candidate reference measurement procedures for serum 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 by using isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 57:441-448. doi: 10.1373/clinchem.2010.152553
43. Sempos CT, Vesper HW, Phinney KW et al (2012) Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 243:32-40. doi: 10.3109/00365513.2012.681935
44. Vernay M, Sponga M, Salavane B et al (2012) Vitamin D status in the French adult population: the French Nutrition and Health Survey (ENNS, 2006-2007). BEH - Bulletin d'Epidémiologie Hebdomadaire 189-197
45. ATIH: Agence Technique de l'Information sur l'Hospitalisation. http://www.atih.sante.fr/. Accessed 2 March 2013
46. (2011) Choix méthodologiques pour l'évaluation économique à la HAS
47. Heaney RP, Davies KM, Chen TC et al (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204-210